Trinordiol (ethinylestradiol 0,03 mg + levonorgestrel 0,05 mg tablet (or.) (I) + ethinylestradiol 0,04 mg + levonorgestrel 0,075 mg tablet (or.) (II) + ethinylestradiol 0,03 mg + levonorgestrel 0,125 mg tablet (or.) (III)) · CNK 0091280

Product information

Trinordiol
3 x 21 (6 + 5 + 10)
ethinylestradiol 0,03 mg + levonorgestrel 0,05 mg tablet (or.) (I) + ethinylestradiol 0,04 mg + levonorgestrel 0,075 mg tablet (or.) (II) + ethinylestradiol 0,03 mg + levonorgestrel 0,125 mg tablet (or.) (III)
0091280
8.88 / 10
Locked

Product properties

57-63-6
G03AB03
Pfizer
Coated tablet
€8.26
BE116907
05415062305270
M2
Public
116907-02

Pharmacist Assessment

Normally available

This product has good current availability (score 8.88/10) and is historically stable (score 🔒/10). No action required.

Note: this product will become temporarily unavailable from 29/07/2026.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 17 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Temporarily unavailable Planned
From 29/07/2026

Delay in production

Adaptation of the treatment possible
Available Active
Until 28/07/2026

Composition

15 ingredients

Substance Type Strength CAS
Active ingredient
50 ug
797-63-7
Active ingredient
30 ug
57-63-6
Excipient
0.136 mg
Excipient
33.07 mg
Excipient
8.582 mg
Excipient
19.297 mg
Active ingredient
40 ug
57-63-6
Active ingredient
75 ug
797-63-7
Excipient
33.035 mg
Excipient
19.66 mg
Active ingredient
125 ug
797-63-7
Active ingredient
30 ug
57-63-6
Excipient
0.135 mg
Excipient
32.995 mg
Excipient
19.223 mg

Additional information

Availability statistics

Available
0 days
2
1